Are age-based strategies effective in increasing influenza vaccination coverage? The Spanish experience

被引:14
|
作者
Jimenez-Garcia, Rodrigo [1 ]
Hernandez-Barrera, Valentin [1 ]
Rodriguez-Rieiro, Cristina [1 ]
Lopez de Andres, Ana [1 ]
de Miguel-Diez, Javier [1 ,2 ]
Jimenez Trujillo, Isabel [1 ]
Carrasco-Garrido, Pilar [1 ]
机构
[1] Rey Juan Carlos Univ, Prevent Med Unit, Madrid, Spain
[2] Hosp Gen Univ Gregario Maranon, Dept Pneumol, Madrid, Spain
关键词
influenza; vaccine; coverage; adherence; strategies; ELDERLY OUTPATIENTS; SEASONAL INFLUENZA; COST-EFFECTIVENESS; HEALTH-CARE; SELF-REPORT; SPAIN; ADULTS; PREVENTION; CHILDREN; MODEL;
D O I
10.4161/hv.18433
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We investigated the effectiveness of applying age-based strategies to improve influenza vaccination coverage in Spain. We described and compared influenza vaccination coverage from 2003 to 2010 between those Spanish autonomous regions (AR) that lowered the age limit to 60 y and those regions that maintained the limit at 65 y. We used data collected from two surveys covering a representative sample of the Spanish population aged >= 16 y [Spanish National Health Survey (SNHS) 2003/2004 and the European Health Survey for Spain (EHSS) 2009/2010]. The study population (persons aged >= 60 y) comprised 7,496 persons in the SNHS and 7,686 in the EHSS. In 2010, those AR which had reduced the age limit had higher coverage for all age groups analyzed-regardless of the presence of associated chronic conditions-than AR which continued vaccination for those >= 65 y. The greatest differences appeared in individuals aged 60 to 64 y (36.9% vs. 24.4% for individuals without chronic conditions, 59.1% vs. 52.9% for those with chronic conditions, and 43.3% vs. 32.3% for the entire age group). Multivariate analysis showed that those AR which lowered the age limit increased total coverage for all age groups, specifically among individuals with chronic conditions aged 60 to 64 y (IRR 1.18; 95% CI, 1.01-1.54) and >= 65 y (IRR 1.07; 95% CI, 1.00-1.14). No significant changes were observed over time for the AR that continued vaccinating people aged >= 65 y. Our results suggest that age-based strategies are effective for improving influenza vaccination coverage in Spain.
引用
收藏
页码:228 / 233
页数:6
相关论文
共 50 条
  • [41] Influenza vaccination coverage rates in Germany -: A population-based cross-sectional analysis of the seasons 2002/2003 and 2003/2004
    Müller, D
    Wutzler, P
    Szucs, TD
    MEDIZINISCHE KLINIK, 2005, 100 (01) : 6 - 13
  • [42] Impact of a website based educational program for increasing vaccination coverage among adolescents
    Esposito, Susanna
    Bianchini, Sonia
    Tagliabue, Claudia
    Umbrello, Giulia
    Madini, Barbara
    Di Pietro, Giada
    Principi, Nicola
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (04) : 961 - 968
  • [43] Increasing influenza vaccination coverage in healthcare workers: analysis of an intensified on-site vaccination campaign during the COVID-19 pandemic
    Sofie Schumacher
    Jon Salmanton-García
    Andrea Liekweg
    Muriel Rolfes
    Danila Seidel
    Sibylle C. Mellinghoff
    Oliver A. Cornely
    Infection, 2023, 51 : 1417 - 1429
  • [44] Increasing influenza vaccination coverage in healthcare workers: analysis of an intensified on-site vaccination campaign during the COVID-19 pandemic
    Schumacher, Sofie
    Salmanton-Garcia, Jon
    Liekweg, Andrea
    Rolfes, Muriel
    Seidel, Danila
    Mellinghoff, Sibylle C.
    Cornely, Oliver A.
    INFECTION, 2023, 51 (05) : 1417 - 1429
  • [45] Strategies for Geriatric Pneumonia in Healthcare Facilities - How Effective is Combined Influenza and Pneumococcal Vaccination?
    Seki, Masafumi
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2020, 13 : 663 - 665
  • [46] Influenza during pregnancy: Incidence, vaccination coverage and attitudes toward vaccination in the French web-based cohort G-GrippeNet
    Loubet, Paul
    Guerrisi, Caroline
    Turbelin, Clement
    Blondel, Beatrice
    Launay, Odile
    Bardou, Marc
    Goffinet, Francois
    Colizza, Vittoria
    Hanslik, Thomas
    Kerneis, Solen
    VACCINE, 2016, 34 (20) : 2390 - 2396
  • [47] The coverage of influenza vaccination and predictors of influenza non-vaccination in Danish cancer patients: A nationwide register-based cohort study
    Amdisen, Lau
    Pedersen, Lars
    Abildgaard, Niels
    Benn, Christine Stabell
    Rorth, Mikael
    Cronin-Fenton, Deirdre
    Sorup, Signe
    VACCINE, 2024, 42 (07) : 1690 - 1697
  • [48] Active vaccination campaign to increase seasonal influenza vaccination coverage: a monocenter experience in a cohort of Italian patients with systemic autoimmune diseases
    Chevallard, Michel
    Adinolfi, Antonella
    Belloli, Laura
    Casu, Cinzia
    Di Cicco, Maria
    Destefani, Chiara
    Di Rosa, Bartolomeo
    Gentile, Maria Giovanna
    Filippini, Davide Antonio
    Luisi, Angela
    Muscara, Marina
    Schito, Emanuela
    Ughi, Nicola
    Verduci, Elisa
    Vincenti, Emanuela Marta
    Zoppini, Laura
    Epis, Oscar Massimiliano
    CLINICAL RHEUMATOLOGY, 2023, 42 (03) : 923 - 928
  • [49] Active vaccination campaign to increase seasonal influenza vaccination coverage: a monocenter experience in a cohort of Italian patients with systemic autoimmune diseases
    Michel Chevallard
    Antonella Adinolfi
    Laura Belloli
    Cinzia Casu
    Maria Di Cicco
    Chiara Destefani
    Bartolomeo Di Rosa
    Maria Giovanna Gentile
    Davide Antonio Filippini
    Angela Luisi
    Marina Muscarà
    Emanuela Schito
    Nicola Ughi
    Elisa Verduci
    Emanuela Marta Vincenti
    Laura Zoppini
    Oscar Massimiliano Epis
    Clinical Rheumatology, 2023, 42 : 923 - 928
  • [50] The estimated age-group specific influenza vaccine coverage rates in Hong Kong and the impact of the school outreach vaccination program
    Wong, Wilfred Hing-Sang
    Peare, Sinead
    Lam, Hiu Ying
    Chow, Chun Bong
    Lau, Yu Lung
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01) : 1 - 5